JP2018052985A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018052985A5 JP2018052985A5 JP2018001740A JP2018001740A JP2018052985A5 JP 2018052985 A5 JP2018052985 A5 JP 2018052985A5 JP 2018001740 A JP2018001740 A JP 2018001740A JP 2018001740 A JP2018001740 A JP 2018001740A JP 2018052985 A5 JP2018052985 A5 JP 2018052985A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- reaction conditions
- conditions comprise
- reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- BEXBCJDNMFRAGD-UWVGGRQHSA-N CC(C)[C@@H](C(N1[C@@H](C)CCC1)=O)NC(OC)=O Chemical compound CC(C)[C@@H](C(N1[C@@H](C)CCC1)=O)NC(OC)=O BEXBCJDNMFRAGD-UWVGGRQHSA-N 0.000 description 2
- QKCHZKBNZMJQJI-ZETCQYMHSA-N C[C@@H](CCC1)N1C(CNC(OC)=O)=O Chemical compound C[C@@H](CCC1)N1C(CNC(OC)=O)=O QKCHZKBNZMJQJI-ZETCQYMHSA-N 0.000 description 2
- AUNYEDWJCMEOBQ-IUXPMGMMSA-N N/C=C(/c1ccc2-c(cc(ccc3c4[nH]cn3)c4c3)c3OCc2c1)\N Chemical compound N/C=C(/c1ccc2-c(cc(ccc3c4[nH]cn3)c4c3)c3OCc2c1)\N AUNYEDWJCMEOBQ-IUXPMGMMSA-N 0.000 description 2
- TXPNLCSGDSXNQP-WUBFSWBHSA-N COC[C@@H](C[C@H]1c2ncc(-c(cc3COc4c5)ccc3-c4cc(cc3)c5c4c3nc[nH]4)[nH]2)CN1C([C@@H](c1ccccc1)NC(OC)=O)=O Chemical compound COC[C@@H](C[C@H]1c2ncc(-c(cc3COc4c5)ccc3-c4cc(cc3)c5c4c3nc[nH]4)[nH]2)CN1C([C@@H](c1ccccc1)NC(OC)=O)=O TXPNLCSGDSXNQP-WUBFSWBHSA-N 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019137834A JP6954959B2 (ja) | 2014-06-11 | 2019-07-26 | 抗ウイルス化合物を調製するためのプロセス |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462010813P | 2014-06-11 | 2014-06-11 | |
| US62/010,813 | 2014-06-11 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016572416A Division JP6295348B2 (ja) | 2014-06-11 | 2015-06-08 | 抗ウイルス化合物を調製するためのプロセス |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019137834A Division JP6954959B2 (ja) | 2014-06-11 | 2019-07-26 | 抗ウイルス化合物を調製するためのプロセス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018052985A JP2018052985A (ja) | 2018-04-05 |
| JP2018052985A5 true JP2018052985A5 (https=) | 2018-07-19 |
Family
ID=53783899
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016572416A Active JP6295348B2 (ja) | 2014-06-11 | 2015-06-08 | 抗ウイルス化合物を調製するためのプロセス |
| JP2018001740A Withdrawn JP2018052985A (ja) | 2014-06-11 | 2018-01-10 | 抗ウイルス化合物を調製するためのプロセス |
| JP2019137834A Active JP6954959B2 (ja) | 2014-06-11 | 2019-07-26 | 抗ウイルス化合物を調製するためのプロセス |
| JP2021133343A Withdrawn JP2021178872A (ja) | 2014-06-11 | 2021-08-18 | 抗ウイルス化合物を調製するためのプロセス |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016572416A Active JP6295348B2 (ja) | 2014-06-11 | 2015-06-08 | 抗ウイルス化合物を調製するためのプロセス |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019137834A Active JP6954959B2 (ja) | 2014-06-11 | 2019-07-26 | 抗ウイルス化合物を調製するためのプロセス |
| JP2021133343A Withdrawn JP2021178872A (ja) | 2014-06-11 | 2021-08-18 | 抗ウイルス化合物を調製するためのプロセス |
Country Status (18)
| Country | Link |
|---|---|
| US (5) | US9670187B2 (https=) |
| EP (1) | EP3154984B1 (https=) |
| JP (4) | JP6295348B2 (https=) |
| KR (2) | KR20180114253A (https=) |
| CN (1) | CN106488920A (https=) |
| AR (1) | AR105050A1 (https=) |
| AU (3) | AU2015274967B2 (https=) |
| BR (1) | BR112016028773B1 (https=) |
| CA (1) | CA2951138C (https=) |
| EA (1) | EA201692219A1 (https=) |
| ES (1) | ES2690868T3 (https=) |
| IL (1) | IL248960A0 (https=) |
| MX (1) | MX2016016297A (https=) |
| NZ (1) | NZ726356A (https=) |
| PT (1) | PT3154984T (https=) |
| SG (1) | SG11201609828SA (https=) |
| TW (2) | TW202014413A (https=) |
| WO (1) | WO2015191437A1 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2345657A1 (en) | 2003-05-30 | 2011-07-20 | Pharmasset, Inc. | Modified fluorinated nucleoside analogues |
| SI2640719T1 (sl) | 2010-11-17 | 2017-07-31 | Gilead Pharmasset Llc | Antivirusne spojine |
| JP6082749B2 (ja) | 2011-11-16 | 2017-02-15 | ギリアド ファーマセット エルエルシー | 抗ウイルス化合物としての縮合イミダゾリルイミダゾール |
| EA201690473A1 (ru) | 2013-08-27 | 2017-03-31 | ГАЙЛИД ФАРМАССЕТ ЭлЭлСи | Комбинированный состав двух противовирусных соединений |
| TWI721947B (zh) | 2014-06-11 | 2021-03-21 | 美商基利法瑪席特有限責任公司 | 抗病毒化合物的固態形式 |
| TW202014413A (zh) * | 2014-06-11 | 2020-04-16 | 美商基利法瑪席特有限責任公司 | 製備抗病毒化合物之方法 |
| US10118890B2 (en) | 2014-10-10 | 2018-11-06 | The Research Foundation For The State University Of New York | Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration |
| WO2017060820A1 (en) * | 2015-10-08 | 2017-04-13 | Mylan Laboratories Limited | Process for the preparation of velpatasvir |
| EP3393585A4 (en) * | 2015-12-21 | 2019-05-08 | Merck Sharp & Dohme Corp. | SILANOUS HETEROCYCLIC COMPOUNDS AND METHOD FOR USE THEREOF FOR THE TREATMENT OF VIRUS DISEASES |
| CN105712969B (zh) * | 2016-01-27 | 2018-07-27 | 杭州科巢生物科技有限公司 | 维帕他韦中间体的合成方法 |
| CN105732765B (zh) * | 2016-02-01 | 2019-07-26 | 杭州科巢生物科技有限公司 | 丙肝药物维帕他韦的新合成方法 |
| CN105732563B (zh) * | 2016-03-23 | 2018-08-28 | 江苏苏利精细化工股份有限公司 | 一种合成9-溴-3-(2-溴乙酰基)-10，11-二氢-5H-二苯并[c,g]色烯-8(9h)-酮的新方法 |
| WO2017191546A1 (en) * | 2016-05-05 | 2017-11-09 | Laurus Labs Private Ltd. | Process for the preparation of intermediates useful in the preparation of hepatitis c virus (hcv) inhibitors |
| CN109071440A (zh) * | 2016-05-13 | 2018-12-21 | 日产化学株式会社 | 2-乙酰基吡啶化合物的制造方法 |
| CN106220639A (zh) * | 2016-07-22 | 2016-12-14 | 上海众强药业有限公司 | 一种维帕他韦中间体新晶型 |
| CN107759577B (zh) * | 2016-11-30 | 2020-03-27 | 上海博志研新药物技术有限公司 | Gs5816中间体、制备方法及应用 |
| CN106831737B (zh) * | 2017-02-27 | 2020-03-17 | 上海众强药业有限公司 | 维帕他韦及其衍生物的制备 |
| CN107629029A (zh) * | 2017-09-19 | 2018-01-26 | 安徽省诚联医药科技有限公司 | 维帕他韦中间体的制备方法 |
| CN107501229A (zh) * | 2017-09-27 | 2017-12-22 | 上海泓博智源医药股份有限公司 | 一种维帕他韦中间体的制备方法 |
| CN107987125A (zh) * | 2017-11-23 | 2018-05-04 | 爱斯特（成都）生物制药股份有限公司 | 一种缬氨酸衍生物的制备方法 |
| CN108218755A (zh) * | 2018-01-18 | 2018-06-29 | 上海仁实医药科技有限公司 | 一种N-Boc-4-氧代-L-脯氨酸叔丁酯的合成工艺 |
| CN110835353B (zh) * | 2018-08-15 | 2022-08-19 | 上海茂晟康慧科技有限公司 | 一种艾日布林中间体er804698的合成方法 |
| CN109265431B (zh) * | 2018-10-09 | 2020-05-26 | 江苏苏利精细化工股份有限公司 | 3-乙酰基-10，11-二氢-5h-二苯并[c,g]色烯-8（9h）-酮合成工艺 |
| IT201900018488A1 (it) * | 2019-10-10 | 2021-04-10 | Dr Schaer S P A | Procedimento di preparazione del tris-(3-idrossibutirrato)-gliceril estere |
| IT201900018491A1 (it) * | 2019-10-10 | 2021-04-10 | Dr Schaer S P A | Procedimento di purificazione del tris-(3-idrossibutirrato)-gliceril estere |
| CN111018870B (zh) * | 2019-11-29 | 2021-07-23 | 南京正济医药研究有限公司 | 一种维帕他韦中间体的制备方法 |
| CN112275146B (zh) * | 2020-09-01 | 2021-08-20 | 中国科学院山西煤炭化学研究所 | 一种经磷酸处理的Tröger`s Base聚合物气体分离膜及其制备方法和应用 |
| CN116462627A (zh) * | 2023-04-19 | 2023-07-21 | 南京优氟医药科技有限公司 | 一种3-溴代哌啶-2,6-二酮的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA201290089A1 (ru) * | 2009-09-04 | 2012-09-28 | ГЛАКСОСМИТКЛАЙН ЭлЭлСи | Химические соединения |
| UA108211C2 (uk) * | 2009-11-04 | 2015-04-10 | Янссен Рід Айрленд | Бензімідазолімідазольні похідні |
| JP2013512246A (ja) * | 2009-11-25 | 2013-04-11 | メルク・シャープ・アンド・ドーム・コーポレーション | ウイルス疾患治療に有用な縮合型三環式化合物およびその誘導体 |
| SI2640719T1 (sl) * | 2010-11-17 | 2017-07-31 | Gilead Pharmasset Llc | Antivirusne spojine |
| JP6082749B2 (ja) * | 2011-11-16 | 2017-02-15 | ギリアド ファーマセット エルエルシー | 抗ウイルス化合物としての縮合イミダゾリルイミダゾール |
| PE20142462A1 (es) * | 2012-02-13 | 2015-02-01 | Presidio Pharmaceuticals Inc | Formas solidas que comprenden inhibidores de ns5a de hcv, sus composiciones y sus usos |
| US20130309196A1 (en) * | 2012-05-16 | 2013-11-21 | Gilead Sciences, Inc. | Antiviral compounds |
| US9056860B2 (en) * | 2012-06-05 | 2015-06-16 | Gilead Pharmasset Llc | Synthesis of antiviral compound |
| EA201690473A1 (ru) | 2013-08-27 | 2017-03-31 | ГАЙЛИД ФАРМАССЕТ ЭлЭлСи | Комбинированный состав двух противовирусных соединений |
| TW202014413A (zh) | 2014-06-11 | 2020-04-16 | 美商基利法瑪席特有限責任公司 | 製備抗病毒化合物之方法 |
| TWI721947B (zh) | 2014-06-11 | 2021-03-21 | 美商基利法瑪席特有限責任公司 | 抗病毒化合物的固態形式 |
-
2015
- 2015-05-28 TW TW108139659A patent/TW202014413A/zh unknown
- 2015-05-28 TW TW104117181A patent/TWI679203B/zh active
- 2015-06-08 NZ NZ726356A patent/NZ726356A/en not_active IP Right Cessation
- 2015-06-08 AU AU2015274967A patent/AU2015274967B2/en active Active
- 2015-06-08 WO PCT/US2015/034655 patent/WO2015191437A1/en not_active Ceased
- 2015-06-08 US US14/733,139 patent/US9670187B2/en active Active
- 2015-06-08 KR KR1020187029248A patent/KR20180114253A/ko not_active Ceased
- 2015-06-08 ES ES15747596.3T patent/ES2690868T3/es active Active
- 2015-06-08 KR KR1020177000461A patent/KR101908642B1/ko active Active
- 2015-06-08 PT PT15747596T patent/PT3154984T/pt unknown
- 2015-06-08 EP EP15747596.3A patent/EP3154984B1/en active Active
- 2015-06-08 SG SG11201609828SA patent/SG11201609828SA/en unknown
- 2015-06-08 EA EA201692219A patent/EA201692219A1/ru unknown
- 2015-06-08 BR BR112016028773-8A patent/BR112016028773B1/pt active IP Right Grant
- 2015-06-08 JP JP2016572416A patent/JP6295348B2/ja active Active
- 2015-06-08 CN CN201580031459.0A patent/CN106488920A/zh active Pending
- 2015-06-08 CA CA2951138A patent/CA2951138C/en active Active
- 2015-06-08 MX MX2016016297A patent/MX2016016297A/es unknown
- 2015-06-10 AR ARP150101834A patent/AR105050A1/es unknown
-
2016
- 2016-11-14 IL IL248960A patent/IL248960A0/en unknown
-
2017
- 2017-04-28 US US15/582,224 patent/US9890134B2/en active Active
- 2017-12-19 US US15/847,803 patent/US20180179175A1/en not_active Abandoned
-
2018
- 2018-01-10 JP JP2018001740A patent/JP2018052985A/ja not_active Withdrawn
- 2018-07-05 AU AU2018204886A patent/AU2018204886B2/en active Active
-
2019
- 2019-05-06 US US16/404,550 patent/US10584109B2/en active Active
- 2019-07-26 JP JP2019137834A patent/JP6954959B2/ja active Active
-
2020
- 2020-01-16 US US16/744,576 patent/US11192875B2/en active Active
- 2020-11-05 AU AU2020264335A patent/AU2020264335B2/en active Active
-
2021
- 2021-08-18 JP JP2021133343A patent/JP2021178872A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018052985A5 (https=) | ||
| JP2018502909A5 (https=) | ||
| JP2012521377A5 (https=) | ||
| JP2008521933A5 (https=) | ||
| JP2018535181A5 (https=) | ||
| EP3414256B1 (en) | Purification process involving amine salt of obeticholic acid | |
| CA2914381A1 (en) | An efficient process for separation of diastereomers of 9-[(r)-2-[[(r,s)-[[(s)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl] methoxy]propyl]adenine | |
| DK155518B (da) | Fremgangsmaade til optisk resolvering af racemisk 1,4-dimethoxy-6-hydroxy-6-acetyltetralin | |
| JP2014510746A5 (https=) | ||
| JP2018516843A5 (https=) | ||
| CN104829590B (zh) | 一种纯化曲格列汀的方法 | |
| JP6228210B2 (ja) | フルボキサミン遊離塩基の精製方法およびそれを用いた高純度フルボキサミンマレイン酸塩の製造方法 | |
| JP5827684B2 (ja) | ２−［３−シアノ−４−（２−ｉ−ブトキシ）フェニル］−４−メチル−５−チアゾール−カルボン酸（フェブキソスタット）の結晶形Ａを調製するための方法 | |
| WO2014195977A2 (en) | Novel polymorphs of vismodegib | |
| CN112194639A (zh) | 一种四咪唑中间体羟盐的制备方法 | |
| JP2012513391A5 (https=) | ||
| JP4700777B2 (ja) | ４−アミノ−１，２，４−トリアゾリン−５−オンの改良された製造方法 | |
| CN105348148B (zh) | 制备达比加群酯中间体缩合物的杂质的草酸盐的方法 | |
| JP2020536898A5 (https=) | ||
| JP2016525094A5 (https=) | ||
| CN106432373A (zh) | 一种全乙酰基葡萄糖的制备方法 | |
| KR100963520B1 (ko) | 이르베사르탄의 개선된 제조방법 | |
| CN111801310A (zh) | 用于生产春烯的方法 | |
| JP2018504374A5 (https=) | ||
| JP2021526513A5 (https=) |